Welcome to our dedicated page for Iperionx SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IperionX Limited filings document foreign private issuer reports, operating updates, governance actions, and market disclosures for a Nasdaq and ASX-listed titanium technology company. Form 6-K exhibits include quarterly reports on titanium powder production and component manufacturing, shareholder letters, investor presentations, meeting materials, ASX correspondence, and notices of company secretary and registered-office changes.
The filings describe the company’s HAMR™ and HSPT™ technologies, Virginia Titanium Manufacturing Campus, Titan critical minerals project, U.S. Department of War grant programs, reimbursement mechanics, equipment procurement treatment, and customer-related manufacturing activity. Governance and ownership disclosures cover shareholder meeting results, equity incentive approvals, director and officer ownership changes, and communications between the company and ASX.
IperionX Limited (NASDAQ: IPX) submitted a Form 6-K on June 27, 2025. The filing is procedural and contains no operating or financial results. Two exhibits are listed:
- Exhibit 99.1 – Notice of General Meeting
- Exhibit 99.2 – Results of Meeting